CD14 and xeroderma pigmentosum: For intermediate monocytes, with CD14 +  + CD16 + phenotype, there was a significant decrease in their percentage in patients with SP-Mel 3.8% ± 1.82 (p-value = 0.009) and in XP patients 3.6% ± 1.16 (p-value = 0.01) compared to healthy controls 9.7% ± 4.6.